Stoelting's Anesthesia and Co-Existing Disease · 8th Edition
Skin and Collagen Disorders
Thank you for studying with us
The website closes on August 31st and the chapter audio moves to YouTube, free. Everything here is unlocked until then.
If you've supported us already — thank you, genuinely. If this helped you and you'd like to put something toward the last of the running costs, it means a lot.
0:00 / 0:00
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
Key Takeaways
- Epidermolysis bullosa and pemphigus require avoidance of adhesive materials and careful airway instrumentation to prevent catastrophic blistering and fluid loss during anesthesia.
- Mastocytosis and urticaria demand preoperative prophylaxis with histamine receptor antagonists and corticosteroids to prevent mast cell degranulation and anaphylactoid reactions.
- Ehlers-Danlos syndrome contraindicates intramuscular injections and regional anesthesia due to severe tissue fragility and uncontrollable hemorrhage risk.
- Muscular dystrophies absolutely contraindicate succinylcholine because exposure triggers rhabdomyolysis, hyperkalemia, and cardiac arrest.
- Myasthenia gravis patients demonstrate unexpected resistance to depolarizing relaxants but extreme sensitivity to nondepolarizing neuromuscular blocking agents.
- Malignant hyperthermia requires total intravenous anesthesia avoidance of volatile agents and immediate dantrolene administration upon clinical crisis recognition.
Chapter SummaryWhat this audio overview covers
Anesthetic management of patients with skin and connective tissue disorders requires comprehensive understanding of how these systemic diseases affect perioperative safety and drug selection. Epidermolysis bullosa and pemphigus present extreme fragility of skin and mucous membranes, where even minor mechanical trauma from standard anesthetic equipment can trigger blistering, airway compromise, and catastrophic fluid loss, necessitating meticulous technique modifications including avoidance of adhesive materials and careful airway instrumentation. Mastocytosis and urticaria disorders involve pathologic mast cell activation that can precipitate anaphylactoid reactions and bronchospasm in response to temperature changes, emotional stress, or histamine-releasing medications, requiring preoperative prophylaxis with receptor antagonists and corticosteroids. Heritable connective tissue disorders fundamentally alter structural integrity throughout the body; Ehlers-Danlos syndrome creates severe tissue fragility and hemorrhage risk that contraindicates intramuscular injections and regional anesthesia, while Marfan syndrome's fibrillin defects cause cardiovascular vulnerability including aortic dissection risk, demanding careful blood pressure management and attention to pneumothorax prevention. Neuromuscular diseases present distinct pharmacologic dangers: muscular dystrophies exhibit absolute contraindication to succinylcholine due to rhabdomyolysis and cardiac arrest risk, myotonic dystrophy requires avoidance of depolarizing agents and strict temperature control to prevent uncontrollable muscle contracture, and myasthenia gravis creates paradoxical sensitivity patterns with resistance to depolarizing agents but exquisite sensitivity to nondepolarizing relaxants. Malignant hyperthermia susceptibility represents a pharmacogenetic emergency where exposure to volatile anesthetics or succinylcholine triggers uncontrolled hypermetabolism, muscle rigidity, and life-threatening electrolyte derangement, requiring total intravenous anesthesia technique and immediate dantrolene administration if crisis develops. Skeletal and systemic autoimmune conditions including rheumatoid arthritis, lupus, and kyphoscoliosis create distinct airway challenges through cervical spine instability, reduced joint mobility, and anatomic deformities, while demanding assessment of multisystem organ involvement that directly influences anesthetic planning and perioperative risk stratification.